Organization · Private Equity
OUROBOROS
OUROBOROS, also known as Ouroboros Group, is a private equity firm based in Tampa, Florida, specializing in middle-market corporate acquisitions and investments in community wellness.
Overview
What OUROBOROS does
What OUROBOROS is
OUROBOROS, also known as Ouroboros Group, is a private equity firm based in Tampa, Florida, specializing in middle-market corporate acquisitions and investments in community wellness.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Private Equity
- Founded
- Founded in 2017
- Approximate age
- About 9 years
- Structured capabilities
- Funder
- Last reviewed
- April 5, 2026
Official channels
Find OUROBOROS elsewhere
Open the official website or a supported primary organization account.
Capability profile
OUROBOROS as a funder
Investment thesis
OUROBOROS focuses on creating sustainable growth and meaningful impact through investments in businesses that enhance community wellness and improve quality-adjusted life years.
Focus narrative
OUROBOROS specializes in investing in businesses that promote community wellness. The fund targets companies that are founder-led, family-linked, or employee-owned, with a focus on sectors such as healthcare, sustainable technologies, and consumer services. The investment range is between $5 million to $100 million, with a target fund size of $1 billion.
Value beyond capital
The fund aims to generate long-term returns while supporting businesses that align with its mission of ethical value growth.
Terms and economics
- Typical check
- $5,000,000–$100,000,000
Focus and fit
- Sectors
- HealthcareConsumer
- Regions
- United States
Availability
- Currently deploying
- Yes
Portfolio and track record
Portfolio context
OUROBOROS has made notable investments, including a leading $60 million Series A investment in Cytotheryx, aimed at advancing a cell therapy platform for liver disease.
Common questions
What to know about OUROBOROS
Upseed classifies OUROBOROS under the Private Equity organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 5, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.